Shoulder Innovations Inc. Common Stock (SI)

Fundamentals

1-day range

$18.88$21.02

Market cap

$465.16M

P/E (trailing)

—

P/E (forward)

-13.12

EPS (trailing)

—

Dividend yield

—

Beta

—

Avg. volume

119.6K

Forecasts

4 analyst ratings

Shoulder Innovations Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SI

  Shoulder Innovations Inc. Common Stock

  $21.16

  ▼ 0.52%
  Market cap $465.16MP/E —
  $10.92$24.6
• CERS

  Cerus Corporation Common Stock

  $2.65

  ▼ 2.57%
  Market cap $467.54MP/E —
  $1.17$3.47
• NPCE

  Neuropace Inc. Common Stock

  $14.41

  ▲ 1.98%
  Market cap $473.90MP/E —
  $8.76$19.6
• MOBI

  Mobia Medical Inc. Common Stock

  $11.37

  ▲ 7.22%
  Market cap $409.63MP/E —
  $10.19$15.29
• SGHT

  Sight Sciences Inc. Common Stock

  $8.54

  ▲ 1.55%
  Market cap $385.77MP/E —
• KIDS

  OrthoPediatrics Corp. Common Stock

  $23.67

  ▲ 1.50%
  Market cap $549.03MP/E —
  $14.42$26.74
• MDXG

  MiMedx Group Inc Common Stock

  $4.49

  ▼ 0.44%
  Market cap $609.28MP/E 98.12
  $3.03$7.97

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• UBS Maintains Buy on Shoulder Innovations, Raises Price Target to $28
  Benzinga · 8/10/2026
• Shoulder Innovations Files $300M Mixed Securities Shelf Prospectus And Registers Resale Of 8,103,026 Common Shares By Selling Stockholders
  Benzinga · 8/7/2026
• Piper Sandler Reiterates Overweight on Shoulder Innovations, Raises Price Target to $25
  Benzinga · 8/7/2026
• BTIG Maintains Buy on Shoulder Innovations, Raises Price Target to $26
  Benzinga · 8/7/2026
• Shoulder Innovations (NYSE:SI) Posts In-Line Q2 Results, Raises Full-Year Outlook
  ChartMill · 8/6/2026
• Shoulder Innovations, Inc. (SI) Q2 2026 Earnings Call Transcript
  SeekingAlpha · 8/6/2026
• Shoulder Innovations Q2 EPS $(0.49) Misses $(0.46) Estimate, Sales $17.175M Beat $16.573M Estimate
  Benzinga · 8/6/2026
• Shoulder Innovations Raises FY2026 Sales Guidance from $65.000M-$68.000M to $67.000M-$69.000M vs $67.283M Est
  Benzinga · 8/6/2026

• Gilde Healthcare Holding B.V. · August 4, 2026 · Sale

  99.8K @ $22.77
• Gilde Healthcare Holding B.V. · August 3, 2026 · Sale

  10.8K @ $22.71
• Gilde Healthcare Holding B.V. · July 31, 2026 · Sale

  20.0K @ $22.73
• Gilde Healthcare Holding B.V. · July 30, 2026 · Sale

  28.2K @ $23.36
• Ahearn Matthew Fraser · June 15, 2026 · Sale

  2.5K @ $19.26
• Ahearn Matthew Fraser · June 15, 2026 · Sale

  1.6K @ $18.2
• Ahearn Matthew Fraser · June 12, 2026 · Sale

  15.9K @ $18.68
• Ball Robert Joseph · April 30, 2026 · Option Exercise

  10.0K @ $2.48
• Ahearn Matthew Fraser · April 20, 2026 · Option Exercise

  14.2K @ $2.86
• Ahearn Matthew Fraser · April 20, 2026 · Option Exercise

  7.4K @ $2.48
• Paul Buckman · March 13, 2026 · Option Exercise

  26.2K @ $2.1
• Paul Buckman · March 13, 2026 · Option Exercise

  19.4K @ $2.48
• Paul Buckman · March 13, 2026 · Tax Withholding

  3.7K @ $14.82
• Paul Buckman · March 13, 2026 · Tax Withholding

  3.3K @ $14.62
• Ball Robert Joseph · March 13, 2026 · Buy

  2.2K @ $15.18

Institutional Ownership

March 31, 2026

Total shares held

7.39M

Total value held

$107.44M

Institutional holders

54